CA2357650C - Stent with optimal strength and radiopacity characteristics - Google Patents

Stent with optimal strength and radiopacity characteristics Download PDF

Info

Publication number
CA2357650C
CA2357650C CA002357650A CA2357650A CA2357650C CA 2357650 C CA2357650 C CA 2357650C CA 002357650 A CA002357650 A CA 002357650A CA 2357650 A CA2357650 A CA 2357650A CA 2357650 C CA2357650 C CA 2357650C
Authority
CA
Canada
Prior art keywords
stent
sets
strut members
sections
strut
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002357650A
Other languages
French (fr)
Other versions
CA2357650A1 (en
Inventor
Robert E. Fischell
David R. Fischell
Janet Burpee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cardinal Health 529 LLC
Original Assignee
Cordis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22881625&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2357650(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cordis Corp filed Critical Cordis Corp
Priority to CA2651808A priority Critical patent/CA2651808C/en
Publication of CA2357650A1 publication Critical patent/CA2357650A1/en
Application granted granted Critical
Publication of CA2357650C publication Critical patent/CA2357650C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91583Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0076Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0032Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in radiographic density
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0036Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Abstract

A stent in the form of a thin-walled, multi-cellular tubular structure is provided. The tubular structure has a longitudinal axis and the stent includes a plurality of circumferential sets of strut members. Each set of the strut members is longitudinally displaced from each other and connected to each other by longitudinally extending links. Each set of the strut members forms a closed and cylindrical portion of the stent. Further, each set of the strut members includes a plurality of connected curve sections and diagonal sections. The sets of the strut members further include end sets of strut members located at each end of the stent and central sets of strut members located between the end sets of the strut members. The diagonal sections of the end sets of the strut members have a center portion and two ends. At least one of the diagonal sections of the end sets of the strut members includes a tapered shape with width of one diagonal section is greater at the center of the diagonal section than the width at either end of the diagonal section.

Description

STENT NVITH OPTIMAL STRE_A'GTH AND RADIOPaCITY CHARACTERISTICS
FIEI_D OF JSE

This invention is in the field o~'stents foi- implantation into a vessel of a human body.
BACKGRO[:ND OF THE INti'ENTION

Stents are well known medical devices that are used for maintaining the patency of a larl-e variety of vessels of the human bodv. A more fi-equent use is for implantation into the coronai-y vasculature. Althoulgh st nts have heen used for this purpose for more than ten vears, and some current stent designs such as the CORDIS BX Velocity IRD
stent, Cordis Corporation, Miami Lakes, FL, have the required flexibility and radial rigidity to provide an excellent clinical result. they are not alwavs clearly seen under standard fluoroscopy.

Many current tubular stentS use a multiplicity of circumferential sets of stnit members eonnected by either strail-ht longitudinal connecting links or undulating longitudinal connecting links. The circumferential sets of strut members are typically formed from a series of diagonal sections connec.ted to curved sections forming a closed-ring, zicy-zac, structure. This structure opens up as the stent expands to form the element in the stent that provides stnictural support for the arterial wa11. A sin~le strut member can be thought of as a diagonal section connected to a cur~,ed section within one of the circumferential sets of strut members. In current stent designs such as the B.X Velocity ~,.~ stent, these sets of stnit members are formed from a single piece of metal having a uniform wall thickness and generally uniform strut width. Although a stent with uniform width of the strut mernbers will function, if the width is inereased to add strength or radiopacity, the sets of stnit members ill zxperience increaseci strain upon z.rpansion. Hi-~-,h strain can cause cracking of the metal and potential tati'~ue failure of the stent under the cyclic stress of a beating hean.

Existin,- hi~hlv radiopadut' stents, such as the ;oid plated NLROYAL stent sold bv Boston Scientific, Inc., Natick MA. can obscure the inside of the vessel due to the hi;h radiopacity over the entire lengt;1 of the stent. The BeStertt sold by Vledtronic. Inc., Vlinneapolis %1N, has small Lyold r;iarkers at the ends of the stent. Those markers only mark an end point without allo\ving visualization ot the cntire end set of stnrt members.

Fischell et al, in L~S Patent No. 6.086,604, discloses a stent with the end sets of strut members bein- gold plated. Such a stent would have ideal radiopacity but may be subject to the corrosive effects incurred tiLrough pfacement of dissimilar metals in an electroi%-tic solution such as blood. There has also been significant evidence that (yold is a poor surface material for stents because it mav increase the risk of subacute thrombosis or restenosis.
Further, Fischell et al, in US Patent No. 5,697,971 discloses in its FIG. 7, a stainless steel stent with inereased width diagonal sections in all the circumferential sets of stnit men7bers.
SUMMARY OF THE NVENTION

An ideallv radiopaque stent would have end sets of strut members that are hichly radiopaque so that they can be readily seen, everi using low power fluoroscopy, and would further contain a central section that is visible but not too bright so as to obscure the Iumen when high power cine film angio7rarns are taken. The stent should also have onlv one material on its outside surface to avoid potential corrosion; that rnaterial should not promote subacute thrombosis or restenosis.

The pi-esent inv~ntion _s a stent that iS desig-ned to have optimal strength and radiopacitv ~vith good biocompatibihtv. Unfonunately, the choices of appropriate biocompatible metals avail.ablc ,~s thir, wail tubing for stent constniction are somewhat linlited. To achieve optimai rad.iopacitv, the stent design of the present invention is adjusted to the specific radiopacitv and strenyth characteristics of the metal from whieh the stent is fabricated. What is more, coati~igs such as parylene may be needed to avoid con-osion from stents with less biocompatible materials and'or dissimilar metals on the stent's outer surface.
Of extreme importance to the prest,nt invention is the achievement of optimal radiopaciry in a stent that ideallv is only 0.004 inclles wall thickness or less. Such a stent would have a pre-deployment outer diameter (protile) that would be at least 0.003 inches less than currentlv marketed stents. Ideally, the steni described herein would have a wall thickness between 0.0025 inches and 0.004 inches.

Described herein are the novel desi-n elements for stents formed frorn the followin~
materials:

1. A highly radiopaque metal such as tantalum;
2. Metals somewhat more radiopaque than stainless steel, such as the cobalt based alloy L605;
3. Stents coated or plated %%,-ith highly radiopaque materials like gold; and
4. Layered materials such as alternative layers of tantalum and stainless steel.

~. The novel design elements tiiat are described l,,erein include:

1. Taoered stn_~.t width ror stents tormed from highlv radiopaque metals.
Althou~h reducin~T the wdth of the lon-itudinall", dia;onal section alone will reduce radiopacity without significantly affectin2 radial stren,~zth, by having a taper on the curved sections of the cii-cumferential sets of strut members, a greatly reduced level of strain upon stent esparision can be achieved without sacrificing radial strength.
This is extremelv important, as it allows a stent to he made much stronger than a stent ,,vith unifoinl %%idth of the strut rnembers while staving %vithin the same stra.in limit for the material.

Tantalum is a nletal that has been used in stents; ~vhich metal is highly radiopaque.
The optimal radiopacity for a stent design using tarttalum could have uniform width for the circumferential sets of strut members and a waJ thicl:ness of about 0.0025 iriches. To provide more radial strength and to reduce the probability of the stent ends flaring out during deployment, a wall thickness of about 0.003 inches to 0.035 inches would be hi;hly desirable. With uniform width sets of strut members, a 0.035 inches wall thiclcness tantalLun stent would be too briclht under cine an-iography. To reduce the r-adiopacity of the design without significantly impacting the raciial strength of the deployed stent, the present invention envisions curved sections and diagonal sections, either or both of which could ha~e a variable or tapered width. The curved sections should be tapered (wider at the center compared to the ends) to reduce sti-ain as previously described. 'The longitudinally diagonal sections can be thinner in the center than at the ends, to reduce radiopacity for the central sets of strut members.

~

It is envisioned that thc- ~7o%zf stent described herein mi-ght have wider diagonal sections for the end sets of stnit members as compared to the central sets of stntt members.
This feature would enharce thz -adiopacity of the ~~nd sets ofstn.it members ,vhile retainin, a moderate level of radiopacity for the central sets of stntt members. It is also envisioned to have both reduced width diagonals and.'or reduced wall thickness for the central sets of stnlt members. It should be rememberec that it is tluoroscopic visualization of the end sets of stnit members that is most important for visuaiizinc, sterits placed inside a coronary artery.

2. Thicker dia<_~:onal sections for metals with radiopacity sli2htlv better than stainless steel. The cobalt/tungsten alloy L605 is a stronger and more radiopaque metal compai-ed to stainless steel. To achieve optimal radiopacity usinc, L605 with uniform width setS of stnit members, the wall thickness is optinially equal to or greater than 0.0045 inches. 'To provide optimal radi.opacity with such a metal in stents of wall thickness 0.004 inches or less, the present invention envisions wider diagonal sections in the sets of stnit members. Thus, the tapered diagonal sections wouid be wi(der tlian the cur%-ed sections. The tapered curved section design for reduced strain may also be hi<-,hlv desirable ;:or stents made from the L605 alloy.

3. End sets of_stnit memberswith thinner curved sections. Stent deliverability into curved coronary arteries is inlproved when the diagonal sections of the end sets of strut members have a decreased length as compared to the length of the diagonal sections of the central sets or str-ut niembers. A shorter len,,)rth of the diagonal sections will also reduce outwai-d flaring upon expansion of the stent.
Decreasing end flaring of the deployed stent is of particular importance for stents having very thin walls.

>

Previous desi,ns thut desct ibe a stent ',~ ith shorter diavonal sections in the end sets of strut me-nbers are limited bv the strain limit a11o,,ved for the end sets of strut men-ibers. As a result. if the end sets of strut members are made as strong as possible ~vhile being limited by the maximum allowable strain ['(:)r that metal, the :;entral sets of strut members will not have optimized radial strength_ The present invention envisions optimizing the radial strength for all sets of stnit members, i.e., the metal in all sets of strut members just reach the maximum allowable strain at the limiting diameter for the stent's expansion. To achieve this desired atti-ibute, the stent described herein has the curved sections of the end sets of strut members bein,-, less \vide than the curved sectiorls of the central sets of strut members.

4. Good side branch arterial access .%hiie rnaintainina small cell size.
The stents described herein are tv-pically closeci cell stents, having a curved section of a central set of stnit mernbers connected to an adjacent set of stnit members by a longitudinally extending hnk. In one embo(liment of the present invention, the circumferential sets of strut members are joined by undulating longi.tudinal connectin; links with each link having a multiplicity of curved segments so as to increase the perimeter of the stent's closed cells. One aspect of the present invention is that the perimeter of each of the stent's closed cells should be at least 9 mm long.
Thi.s design parameter allo,ws each cell of the stent to be expanded to a circular diameter of approxinlately 3 mm (i.e., 9/n mm -- 3 mm). This feature allows the '`unjailing" of side branches of the artery into which the stent is placed.
The ideal desian to be radiallv strong, prevent plaque prolapse and still allow sidebranch access will have a maximum deployed cell area of less than 0.005 in.2 while havin, a cell perimeter that is at least 9 ntni in length, so as to allow unjailing of side branches. A
;ood cell for side branch access should have a perimeter lencyth between 9 mm and 11 mm. (i.e. an expandablc ;irc.u!ar (diameter bet%veen 2.S6 mm and 3.5 mm). Cell perimeters berween 9.5 and :i) n,.m are optimal.
5. Flexible tlndulatin~-Y lon~iitudinal links with good support between a(iiacent sets of strut mertlbers. To provide a strong bridge connection between adjacent circumferential sets of stnit members, the flexible undulating longitudinal connectin,-) links should !la~ ne-.rlv equal extension in the circumferential direction on each side of a line drativn between the attachment poirits of the flexible undulatinc, lon,gitudinal connecting linl: to the curved sections of adjacent sets of strut members.
"N" and inverted "N" sliapes for the connecting links inherently have equal cireumferential displaceme:it on each side of the line connecting their attachment points. The specially designed "M" or "'vV" shapes of the present invention also provide this desirable attribute. Nearly equal circumferential len~ths on either side of a line drawn between the attachment points of the flexible undulating longitudinal connecting links help in prcventing plaque from pushing the "M" or "W" shaped link imvard into the lumen of the stent when the stent is deployed into an artery.

The "M" and "W" shapes ar'e of particular advantage in obtaining the desired attribute of small area cells that have good side branch access capability because of an increased perimeter length. It should also be understood that the -`M" and "W" shapes each add an additional half cycle of undulatitl-, link 1enlgth to the cell perimeter as compared to an "N"
shaped link design, thus improving the stent's longitudinal tlexibility. It should also be noted that a "W" link is simply an inverted "iti1" link.
6. Variable thickness radiopaque coatings. The NIROYAL TIM stent has a tuZiform thickness of ;o1d platin~-,, which makes the center too radiopaque as compared to the radiopacit,, of the end sets of strut mennbers. Fischel[ et al.. US
Patent No. 6,0S6,6i)4, tet.ches stents ha%in- Uoid placed at the end sets of strut members. This creates a potential for corrosion frorYt dissimilar metals, namelv, ~,o1d and stainless steel. The present invention envisions a gold coating that is sufficientl%thick on the end sets ot strut m.embers to provide optimai radiopacity -with a thin coating of -old on the rest of the stent. This design prevents obscuring of the arterial lunlen while providing an exterior surface. for the stent that is a single metal, thus avoiding electrolyZic corrosion.
7. Polvmer coatinLgs for stents coated with. gold or havin2 dissimilar metal surfaces. For stents with non-biocompatible or dissinlilar metals, the present invention envisions the us~; of a polymer such as parylene to coat the entire outer surface of the stent. Thi.s would improve biocompatibility and also allow attachment of oraanic compounds such as lleparin or phospllorylcholine for reduced thrombovenicity or drugs. such as taxol or rapamycin, for reduced cell proliferation and a decreased rate of restenosis. It is also known that highl,v radiopaque rnaterials like tungsten can be mixed into polymers. A stent coatincy including a plastic with mixed in radiopaque metal could be ased to enhance both radiopacity and biocompatibility. Such a polymer coating could also be advantageous with a-old coated stent.
8. Providiu a variable wall thickness. The present invention also envisioils next generation manufacturing techniques using photo-etching, whereby a stent pattem is etched into a thin-walled metal tube. These techniques already can produce variations in wall thickness as well as strut width for any stent pattern. The present invention envisions use of these techniques to create stents with optimal ~

radiopacity. In particular to~ a stent forrneci from a single metal or alloy, thicker rnetal at eacll end of th,~ stent could increase radiopaci.ty there as compared to the central section of the ster.t. Pcrhaps more important is the use of multi-thickness etching techniques with a two- or three- layered tube where one of the layers is a highly radiopaque material such as tantalum. For example, a two-layer tube havincy one layer of stainless steel and a second layer of tantalurn could be etched to provide the end sets of strut membCrs with 0.001 inches of tantalum and 0.0025 inches of stainless steel while the i-ernainder of the stent would have less than 0.0005 inches of tantalum with a stainless steel layer of 0.003 inches. It is also envisioneci that there could be tantaluni only on the ertd sets of strut members. Thus, one could produce a stent with enhanced radiopacity at the ends with the stent having a uniform wall thickness.

One could even have a stent with increased wall thickness of a metal at the central region of the stent but still having a ciecreased radiopacity at that central region if, for example, the stent had tantalum end struts with stainless steel center struts.
Such a stent would be strongest in the center where the thickest plaque must be restrained.

It is also envisioned that any of the above optimal radiopacity stent designs may be used with plastic coatin(ys such as parylene, antithrombogenic coatings such as heparin or phosphorylcholine, or anti-proliferative coatings such as taxol or rapamycin.

Thus it is an object of the present invention to have a stent with tapered curved sections, the center of the curved sections being wider than ends of the curved sections so as to reduce plastic strain as the stent is expanded as compared to a curved section with uniform width.

~~

.another object of the prcsent invention is to have a stent with tapered diagonal sections in the sets of strut membcrs %vhere the center of the dia~ronal section is narrower than the ends to reduce the radiopaci:%, of central sets of strut membet-s of the stent as compared to a stent with diaconal sections havinu- a uniform width.

Still another object of the. invention is to have a stent with decreased wall thickness at the central stnits compared to tl-ie end struts so as to have a comparatively hio'her radiopacity foi- the end sets of stn.it members.

Still another object of the present invention is to have a stent with tapered diagonal sections for one or more of the set.s of stntt members ~vhere the center of the diagonal section is wider than the ends to increase the radiopacity of the end sets of strut niembers as compared to a stent with uniform width of the diaUonal sections.

Still another object of the present invention is to have end sets of strut members having both shorter diagonal sections and thinner width curved sections as compared to those sections in the central sets of strut rnembers.

Still another object of the present invention is to have a tantalum stent with wall thickness less than 0.035 inches having tapered sets of strut members whereby the diagonal sections are less wide than the width at the center o f the curved sections.

Still another object of the present invention is to have a closed cell stent design with maximum post-deployment cell area less than 0.005 square inches and a cell perimeter length that is edual to or greater than 9 mrr!.

I

'Still unother object of thc preSent in~'ention is to have a stent with a radiopaque metai coatina where the radiopaque n-~eta.l coating Ilas greater wall thickness on the end sets of stnit members as compared to thickncss on the szts of str-ut members at the center of the stent.

Still another object of the present invention :s to have a stent etched from a muiti-laver metal tube having one layer signiticantlv more radiopaque than at least one other laver;
the etched stent being formed with increased wall thickness of the more radiopaque layer on the end sets of strut menibers as compared with the sets of strut members at the center of the stent.

Still another object of the present invention is to have a closed cell stent design with "M" or "W" shaped flexible undulating longitudinal connecting links wherein the circumferential extent of the flexible undulating longitudinal connectinQ
iinks is appi-oximately equal on each side i.,f a line drawn between the proximal and distal attachment points of the flexible undulating longitudinal connecting link.

Still another object of the present invention is to have the stent with optimized radiopacity formed with an outer surface that is plastic coated to improve biocompatibility.
Still another object of the present invention is to have the stent with optimized radiopacity that is coated with a plastic material and an additional organic compound to prevent thrombus formation and/or restenosis.

Still another object of the present invention is to have a stent coated with a plastic material that includes a radiopaquC riller material.

These and other objects ard advantaves o: this invention will become apparent to the person of ordinary skill in this art fieid upon reading of the detailed description of this invention includinL), the associated dra%v:nLs.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a tlat layout a prior art stent having uniform strut width for the circumferential sets of strut members.

FIG. 2 is a flat layout of a prior art stent design having "M" and "W"
flexible connecting links.

FIG. j' is an enlaruement of the -ti1" link of the stent desi.~,n of FIG. 2.

FIG. 4 is an enlargement of the improved "M" liiik- design of the present invention.
FIG. 5 is a tlat layout of the present invention stent design for a highly radiopaque metal.

FIG. 6 is a flat layout of part of the present invention stent design of FIG.
5.

FIG. 7 is a flat layout of an alternate embodiment of part of the present invention stent design of FIG. 5.

FIG. S is a flat layout of the present invention stent desiorn for a somewhat t-adiopaque metal.

FIG. 9 is a flat lavout of the present inven:ion stent design for a stent coated with a radiopaque metal.

FIG. 10 is a flat layout of an alternate embodiment of the present invention stent including an "N" shaped fleYible connecting link.

FIG. 11 is a flat layout of the present invention stent design as photo-etched from a tube.

FIG. l?;a is an enlargement ot a section of tlie photo-etched stent of FIG.
11.
i FIG. 1?B is a fon~itudinal cross section a.t l:'.-1 ~ of the enlarged section of FIG. 11 shown in FIG. 12A, the stent h<ving a radiopaquc coating that is thickest on the erid sets of strut members.

FIG. 12C is a lon-itudinal cross section at 1~,'-12 of the enlarged section of FIG. 11 shown in FIG. 12A, as etched fi-om a two-laver tube where one of the tube lavers is a moderately radiopaque metal and the other layer is a highly radiopaque metal.
DETAIL.ED DESCRIPTION (DF THE DRAWINGS

FIG. I shows a flat layout of an embodiment of a prior art stent described by Fischell et al in U.S. Patent No. 6,190,403). The stent 5 of FIG. 1 is shown in its crimped, pre-deployed state as it would appear if it were cut longitudinally and then laid out into a flat, ?-dimensional conficuration. The stent 5 comprises end sets of strut members 2 located at each end of the stent 5 and three central sets of strut members 6 connected each to the other bv sets of longitudinally extendinc, undulatin-, "N" links 4. The end sets of stnit members 2 consist of alternatino- curved sections 7 and diagonal sections 9. The central sets of stnit nzembers 6 located longitudina(lv between the end sets of strut members 2 consist of alternatin- curved sections 3 and diagonal sections S. In the prior art stent 5, the longitudinally diagonal sections 9 of the end sets of strut members 2 are shorter in lencyth than the longitudinally diagonal sections 8 of the central sets of strut members 6. The shorter diagonal sections 9 will reduce the stiff longitudinal lencrth of metal at the ends of the stent 5 to improve deliverabilitv (by reducinc, "fish-scaling") and will also increase the post-expansion strength of the end sets of strut members 2 as compared with the central sets of strut members 6. In this prior art stent, the width of the curved sections 3 and 7 and the diagonal sections 8 and 9 are all the same. "There is no variation in width within any set of strut members or between the e.nc1 sets of stnit members 2 and the central sets of stnit members 6. The stent 5 is a desi,-,n w II si.ited to stainless steel having a wall thickness of 0.0045" or greater, such as found :n thc COIZDIS BX Velocity ~~ stent.

If the stent 5 wei-e fonned from a hi~-,hly radiopaque metal such as tantalum with wall thickness of 0.0030 to 0.0035 inches and with sets of strut inenZbers 6 having widths of greater than the 0.005 inches that is necessary for good radial strength, then the stent would be too radiopaque. In addition, %%ith a wall thickness of 0.003 inches or less, the end sets of sti-ut members 2 might have a tendencv to tlare outwardly into the vessel wall upon expansion. If the end sets of' strut members 2 are designed to be as strong as possible while not exceeding metal strain limits at the largest usable diameter of the stent 5, then the central sets of strut members 6 with lon,er diagonal sections 8 will not have maximized radial stren,-,th assuming the same strLlt ~%idth for both central sets of strut members 6 and end sets of strut members 2. Optimized strength at the longitudinal center of a stent is important as it is that region that must typicall~hold back a larger amount of plaque than at the ends of the stent.

One embodiment of the present invention provides that each set of stnit members should have niarimized radial strength i-ather than having the central sets of stnrt members 6 being less strong than the end sets of strt.tt rnembers as previously described. This design would be similar to the stent 5 of FIG. I with the novel improvement being that the width of the curved sections 3 of the centl-al sets of strut members 6 vvould be greater than the width of the curved sections 7 of the end sets of strut mernbers 2. The greater width of the curved sections 3 will increase the strength of the central sets of strut members 6 compensating for loss of radial strength because of the longer diagonal sections S.

The stent 60 shown in FIG. 2 is a flat layout of a prior art stent design havina "N", "A1" and "W" flexible corinecting, lir:ks. Tiie stent 60 is shown in its crimped pre-depioyed state as it would appear if it wcre cut 1on-Dinrdinally and then laid out into a flat, ?-dimensional confiauration. It should be clearly uriderstood that the stent 60 is in fact cylindrical in shape, which cvlindrical shape would be obtained by rolling the flat confiQuration of FIG. 2 into a cylinder wit11 the top points "G" joined to the bottom points "H". The stent 60 is typically fabricated by laser rnachining of a cylindrical, stainless steel tube.

A central set of strut members 62 is a cylindrical, ctosed, ring-like section of the stent 60 consisting of a multiplicity of curved sectioris 63 connected to diagonal sections 68.
Every curved section 63 of eacli central set of strut members 62 is attached to a connecting link which is either a flexible "N" link =I4, "M" link 64 or a "W" link 84.
The stent 60 also has two end sets of stn.it members 72 consisting of a multiplicity of curved sections 73 connected to diagonal sections 78. In this embodiment, half of the curved sections 73 of the end set of strut members 72 are attached to "N" links 44 with the other half of the curved sections 73 situated at the extreme ends of the stent 60. The diagonal sections 78 of the end sets of stn.it members 72 are shorter than the diagonal sections 68 of the central sets of strut members 62. Shorter diagonal sections enhance the post-expansion radial strength of the end sets of strut members 72 as compared to the central sets of strut members 62.

FIG. 3 is an enlarl-ement of the "M" link 64 of the prior art stent of FIG. 2.
One disadvantage of this design relates to the circumferential extent of the "M"
link 64 with respect to a line 65 that could be drawn between the two attachment points 68 where the "M"
link 64 attaches to the curved sections 63. Because almost all of the "M" link 64 lies above the line 65, pressure on the top of tl,e "M" link 64 from plaque in an artery could bend the top 1~

of tlie "%1" link 64 in%tiard into the ;3rterial <urnen. This vvould be hi(&ly undesirable. Ideail., an tiI" or linti should ha ~. an equa1 Circilmfei-enr_ia1 extent on either side of a Iine drawn between the attachment points to adjacent se,ts of str-ut rnembers as shown in FIG. 4.

One aspect of the present invention is an improved "M" link 14 as shovvn in FIG. 4.
The "'.vt" link 14 has a circumferential extent (i.e., len,~,th) L' above and L" below the line 15.
The line 15 is dra~~n between the attachment points 18 ~vhere the "M" link 14 attaches to adjacent curved sections 13. Such a balanced desigi1%vould diminish any likelihood of the tlexible connecting link 14 from e>:panding into the arterial lumen.

FIG. 5 is a tlat lavout view of a stent 20 that includes some embodiments of the present imention. The design of FIG. 5 is particularly applicable to stents made from a hMhlv radiopaque metat such as tantalum. The stent 20 of FIG. 5 is shown in flat, layout view based on its pre-deployed state, as it would appear before it is crimped onto a balloon catheter. The stent 20 comprises end sets of stnrt members 22 located at each end of the stent 20 and central sets of strut members 26 connecteci each to the other by sets of' individual flexible "M" links 24. The "M" links -14 are similar to the "M" linkI4 of FIG.
4. The end sets of strut members 22 consist of a multiplicity of curved sections 27 connected to diagonal sections 29. The central sets of strut members 26 located lonuitudinally between the end sets of strut members ?2 consist of a multiplicity of curved sections 23 connected to diagonal sections 28.

One can also define a strut element 25 as being composed of one adjacent curved section 23 joined to a diagonal section 28. As seen in FIG. 5, it is clear that one can describe a central set of strut members 26 as beinz a closed, circumferential, ring-like structure 1i:

comprising a multipiicity of coi:nected strut clements 25. An end set of strut members could be !ikewise detined as bein', a n~.u.tiplicity of connected strut elements 17.

The stent 20 is a ctosed cell stent having ceils 19 formed frorn portions of adjacent sets of stnit members corulected by "AI" links 24. F'or coronary arteries, prolapse of plaque into the arterial lumen will be minirnized if the area within the cell 19 does not exceed 0.005 square inches at all diameters up to the ma_Yimum deployment diameter of the stent 20. An important aspect of stent design is to be able to place a 1cuidewire through the expanded cell 19, into a side branch vessel. A balloon angioplasty catheter can then be advanced over the guidewire and intlated to enlar~e and ciretilarize the opening of the cell 19 to "unjail" the side branch vessel. By "unjailin,~" is meant removing metal from the ostium of the side brancli vessel, thus impro\ing 10lood flow to that side branch. One concept of the present invention is that the cell 19 has an interior length of the penmeter that is at least 9 mm. Since balloon dilatation of the cell 19 would cause it to be near circular, an inside perinleter ten,-,th around inside of the cell 19 would provide an inside diameter of 9!n, which is approximately 3 mm. azood cell desiQn for side branch access should have an inside perimeter length between 9 mm and I 1 n1m. (i.e., an expanded inside circular diameter between 2.86 and 3.5 mm) where cell perimeters between 9.5 and 10 mm are optimal and would be suitable for essentially anv side branch of a coronary artery.

In the stent 20, the diagorial sections 29 of the end sets of strut members 22 are shorter in length than the diagonal sections 28 of the central sets of strut members 26. The shorter dial-onal sections 29 will reduce the longitudinal extent of the metal strut at the end of the stent to improve deliverability into a vessel of the human body by decreasing fish-scaling.
In the stent 20, the width of the cucved sections 23 and 27 and the diagonal sections 28 and 29 are different as compared to the prior art stents ~ and 6 of FIGURES I and 2.

The exact design of the ster,t 2U is most clearlv seen in the expanded view of the stent section 21 of FIG. 5 as shown enlar--ed in FIG. 6. FIG. 6 shows that the curved sections _23 (of the central sets of strut members 26 of FIG. 5 ) have a,vidth at the center of the curve ~V,.
The width of the curved sections 23 taper down as one moves away from the center of the curve uritil a minimum width W i is reached at the center of the section 28.
To achieve this taper, the inside arc of the curved section 23 has a center that is longitudinally displaced from the center of the outside arc. This tapered shape for the curved section 23 provides a siUni.ficant reduction in metal strain witll little eftect on the radial strength of the expanded stent as compared to a stent having sets of strut menlbers ith a uniform stnit width.

This reduced strain design has several ad%antages. First, it can allow the present invention desi(zn to have a much `;i-eater usable range of i-adial expansion as compared to a stent %\ith a uniform strut width. Second, it can ailow the width at the center of the cun-e to be increased which increases radial strenath with(Alt (-jreatl;- increasin,,, the metal strain (i.e.
one can make a stron-er stent). Finallv, the taper reduces the amount of metal in the stent and that should improve the stent tl,rombogenicity.

FIG. 6 also shows a unique design for tl.e end sets of strut members 22. The diagonal sections of the end sets of strut members 22 have a leriath L d that is shorter than the len-th L of the diaconal sections 28 of the centrat sets of strut members 26. To maximize the`-tadial strencth of a stent alonry its entire iength, each set of strut members should just reach the maximum allowable plastic strain for the metal bein- used at the largest allowable ezpanded diameter of the stent. [n the stent of FIG 1, the curved sections 7 of the end sets of strut members 2 and the curved sections 3 of the central sets of stnit members Ei have the same widths. As a result, the end sets of strut members 2(which have shorter diaUonal sections 9) will reach the maxir-num allowabie di=eter at a level of strain that is greater than the level of strain zxperien~-ed b~. ihe central sets ot strut members 6.

an optimum stren-th stent desi~m wouid have the same strain at the maYimum stent diameter for both the enct sets ot'stt-ut members 2 and the central sets of strut members 6. For the stent design of FIGS. 5 and 6. one desires to have the end sets of strut members 22 reach the maximum strain limit at the same stent diameter as the central sets of strut rriembers 26.
The present invention teaches a design with the width at the center of the cun,e W, .,, of the curved section 27 bein,, less than the width W~ of the cun'ed sections 23 of the central sets of strut members 26. This reduced width tor the curved sections 23 compensates for the shorter length L,,,,, of the end diagonal sec:tions 29 so that there is the same strain in both the central and end sets of strut nlembers ?2 and 26 respectively as the stent 20 is expanded to its maximum allowable diameter.

The end sets of stnit menibers 22 can also be tapered like the central sets of strut members 26 where the %vidth of the strut tapers down as one moves away from the center of the curve of the cur-ved sections 17 until a minimurn width Wd c- ~, is reached at the diagonal section 29. The curved sections 23, 27 each have an inside (concave) arc and an outside (convex) arc. Each arc has a center that is longitudinally displaced from the other center.

The tapered stnit design shown in FIGS. 5 and 6 also has an advantage for stents made from highly radiopaque nietals such as tantalum. If one uses uniform strut width as seen with the stent 5 of FIG. 1, ttien a properly designed thin-walled (0.0025 inches to 0.035 inches) wall tantalum stent may be too radiopaqt.ie. The reduced metal from the thinner diagonal sections 28 and 29 will decrease the radiopacity without affectinc, radial strength.
1 ~~

Nominal dimensions and dimensiwn ran-es (al1 in inches) for a tantalum stent produced usinCl the desiizn of FIG. 5 are as 60ilo,w:,:

Element Nominal Range W' --- 0.006 0.0045 to 0.007 ----__ 0.0045 0Ø35 to i).005 0.0045 0.004 to 0.005 0.0045 0.0;35 to 0.005 L 0.028 0.0?0 to 0.030 0.015 to 0.026 Wall Thickness 0_0(,-)3 0.0025 to 0.035 AIthou2h the present invention shows the "M" shaped flexible link 24 being used, the present invention stnit designs wi11 function vvith any link shape including "N", "W", "S"
"U", "V" and inverted "N", "U" and "V" designs. It should also be noted that the "N1" linl:
2-I shown in FIG. 6 has esactly tive longitudinaliy extending curved segments 2=1A, 24B, 24C, 24D and 24E.

FIG. 7 is an alternative embodiment 21' ot section 21 sho\vn in FIG. 6 of the present invention stent 20 of FIG. 5. In this embodiment, the onlv difference is the shape of the dia~zonal sections 28'. The diagonal sections 28 of FIG. 6 have uniform thickness. The dia;onaf sections 28' of FIG. 7 are tapered frotr: a width W,j'T at the end of the diagonal section 28' where it connects to the curved sections 23' to a width W.' at the center of the dia,-,onal section 28'. The advanta~!e of the inward taper of the diagonal sections 28' is that removal of more metal will reduce the radiopacity of the longitudinal center region of the stent 20 as compared to a stent with uniform width diagonal sections 28 as seen in FIG. 6.
The additional taper may also further reduce the metal strain as the stent is expanded.
Althou2h one could taper the diagonal sections 29 of the end sets of strut members 22 of FIG. 5, there is an advantage in having the end sets of strut members 22 being more radiopaque than the central sets of strut members 26. This is because visualization of the stent ends is the most important aspect of radiopacitv for a stent. Therefore, a preferred ~!J

embodiment of the prescnt invenrion is as seen in FIG. 7 to have tapered diagonal sections '_S' in the central sets of strut members 26 and rrniform thicl:ness diagonal sections ~9 (having a.zreater average widthi tor the end sets of strut members 22.

Instead of connectinc-I e\"erv eurved section with a tlexible link, an alternate embodiment may use straight links connectin- onlv half of the curved sections of the sets of stnit menibers. Such a stent could also have the advantage of a reduced strain strut desi~n as shown in FIGS. 5, 6 and 7.

For the stent of FIG. 5, it Should also be understood that the wall thickness of the central set of strut members 26 could be thiriner that the wall thickness of the end set of strut nlembers 22. Also it should be ioted that the "M" links 24 also have a much narrower width as compared to the width of any strut member oi the end set of strut members.
Both these attributes of the stent 20 create the following desirable radiopacity characteristics: hi~hlv radiopaque end sets of strut mernbers and decreased radiopacity at the central region of the stent 20.

FIG. 8 is a flat layout view of another embodiment of the present invention showinz a stent 30 made from a moderatefv radiopaque metal such as the cobalt-tungsten alloy L605.
The alloy L605 has great radial strength and is approximately 20% to 30% more radiopaque than stainless steel. Therefore, with L605, the same level of radiopacity is achieved with a stent wall thickness that is 20% to 30 ' less than a stent made from stainless steel. One 'goal in the use of L605 would be to reduce the wall thickness by 30% but end up with a stent that is still more radiopaque than an equivatent stainless steel stent such as the stent 5 shown in FIG. 1.

?1 The stent 30 of FIG. 8 is ~ilown in a iavout vi~w base(i on its pre-deployed state, as it would appear before it is crimptd )nto a balloon catheter. The stent 30 comprises end sets of strut members 321 located at each nd of the stent 30 and central sets of stnrt members 36 connected each to the other by sets of tlexible '"M" links 34. The "N1" links 34 are similar to the "ti'I" links 14 of FIG. 4. Each end set of stnrti members 32 comprises alternatinu curved sections 3 7 and diagonal sections 39 connected togethei- to foml a closed circamferential structure. The central sets of stn~t members 36 iocated lon7itudinally between the end sets of stnit members 32 comprises curved sections 33 and diazonal sections 38 connected to,4ether to form a closed circumferentiai ring-like stnicture.

In the stent 30, the dia,onal sections 39 of the end sets of strut members 32 are shorter in length than the diagonal sections 33 of the central sets of strut members 36. The shorter diagonal sections 39 will reduce the lon4itudinal length of metal at the end of the stent to improve deliverability into a vessel of the Inrman body. In the stent 30, the widths of the dia~_,onal sections 38 and 39 are different as compared to the prior art stents 5 and 60 of FIGS. 1 and 2.

The novel concepts of the stent of FIG. S are shown most clearly in the expanded view of the stent section 31 shown in FIG. 9. In FIG. 9 it can be seen that the diagonal sections 38 of the central sets of strut members 36 have a width at the center T, and a width at the end T, where the width in the center T` is lar2er than the width at the end T. This allows for increased radiopacity without affecting the design of curved sections 33 that are the primary stent elements involved for stent expansion. The curved sections 33 and 37 shown in FIG. 9 are tapered similar to the curved sections 23 and 27 of FIG.
6. It is also envisioned that the curved sections 33 and 37 could have uniform width similar to the curved sections 3 and 7 of FIG. l. The dia,zonal sections 29 of the end sets of strut members 32 also have a tapered shape. The diagonal sections 3) 7 have a width in the center T, ,,d and a width at the erld T. ~ where the width i.1 the center T, _~~ is 1ar~er than the width at the end T, nu.
Because of the desire for the end <ets of strut members 32 to be the most radiopaque part of the stent 30, the diagonal section 39 center width T, _.,n, of the end sets of strut members 32 is shown in FIG. 9 to be wider than the width T, of the diagonal section 38. A
wicier piece of metal will be more radiopaque. 'Thus, the stent has curved sections with a single bend connecting the diagonal sections oi' its sets of strut rnembers, and flexible connecting links connecting the curved sections of its circumferential sets ot strut members.

The stent of FIG. 10 is an alternate embodirnent of the present invention showing central sets of strut members 46 having curved sections 43 and diagonal sections 48 with tapered shapes similar in design to the curved sections 23' and diagonal sections 28' of the stent section ? 1' shown in FIG. 7. The stent 40. of FIG. 10 is shown in a layout view in its pre-deployed state as it would appear before it is crimped onto a balloon catheter. The stent 40 comprises end sets of strut nienibers 42 located at each end of the stent 40 and central sets of strut members 46. The sets of strut members 42 and 46 are connected each to the other by sets of individual fleYible "N" links 44. The "N" links 44 are similar in shape but slightly longer than the "N" links 4 of F1G. 1. The end sets of strut members 42 consist of curved sections 47 and diagonal sections 49. The central sets of strut members 46 located longitudinally between the end sets of stn.it members 42 consist of curved sections 43 and diagonal sections 48.

The stent 40 is a closed cell stent having cells 45 formed from portions of adjacent sets of strut members connected by "N" links 44. Prolapse of plaque through the closed cells 45 is minimized if the expanded area of the cell 45 is less than about 0.005 in.'' at any diameter up to the masimum deplo1,11nent diameter of the stent 40. It is also important for an optimum stent desit-Tn that uruidetivir-:: can be pla:;ed through the expanded cell 45 into a side branch vessel. A balloon an>iopl~st~~ catheter then he advanced over the ~uide ;re, throu-h the cell 45 and inflated to "uniail" the side branch, i.e. remove anv stent strut that is blocking blood flow into that side branch. The present invention design should have an interior perimeter of the cell 45 that is at least 9 mm, thus allowing a nearly 3 mm diameter circular opening to be achieved :or unjailing.

FIG. 1 1 is a flat layout view of another embodiment of' the present invention in the fomi of a stent 50 that is photo-etched fron7 a metal tube. The stent 50 is shown in its pre-deployed state as it wouid appear before it is crimped onto a balloon catheter. Tlie stent 50 comprises end sets of stnit members 52P and 52D located respectively at the proxinlal and distal ends of the stent 50. The sternt 50 also has central sets of strut members 56 connected each to the other by sets of flexible "NI" links 54 The "M" links 54 are similar to the "y-1"
links 14 of FIG. 4. The end sets of stnit members 52P and 52D each consists of cun-ed sections 57 and diagonal sectior.s 59. The central sets of stntt members 56 located longitudinally between the end se:s of strut members 52 consist of curved sections 53 and diagonal sections 58.

The section 55 of the photo-etched stent 50 is sho~vn enlarged in FIG. 12A.
The FIGS. 12B and 12C show two etnbodiments of the present invention that can provide a stent with enhanced radiopacity at the stent ends.

FIG. 12A shows diagonal sections 58 and 59 and an "M" link 54 conrlecting the curved sections 53 and 57.

FIG. 12B is a[on-,ituciinal cross section at 11 2-1? of the stent section 55 shown in FIG.
1?A. The stent desi,-,n sl:own in F[G. ':21B has a ilighlv radiopaque coating that is thicker on the end sets of strut menlbers as compared to the thickness on either the flex links 54 or the central sets of strut members 56. FIG. :?B shows the coating 57C on the curved section 57 of the end set of strut members 521 being, thicker than the coating 54C on the flex link 54 and also thicker than the coatin~ 5~C on the cun~ed section 53. The most likely coating for the stent 50 would be ~2old oLting although p1=:.tinum, tantalum or any other highlv radiopaque metal could be used.

The present invention llas the entire stent coated to provide an exterior surface for the stent 50 that is formed from a sin~~le metal. This reduces the potential for corrosion that can occur with dissimilar metals on rhe stent's exterior sui-face when the stent is placeci in a saline solution such as blood.

It is also envisioned that: even with the entire stent coated with a highly radiopaque metal, an additional coating of a flexible plastic such as parylene may be desirable. Such an organic coating has the additional advantage of allowing the attachment of drugs such as taxol or rapamycin to reduce resterlosis. Techniques for 'gold plating metals such as stainless steel and controlling the thickness of the plating are well known in the art of metal plating.

FIG. 12C is the longitudinal cross section at 12-12 of yet another alternate embodiment of the enlarued section 55 of FIG. 11 shown in FIG. 12A. The stent design shown in FIG. 12C is etched frorn a two-layer tube where one of'the tube layers is a metal of conventional radiopacity such as stainless steel and the other layer is a highly radiopaque metal such as tantalum. AlthouIYh the total wall thickness of the stent of this embodiment remains nearly constant, the end sets of strut members 52' have a thicker layer of the -J

radiopaque metal than the tlex lin.l:s -54' or the centrai sets of strn.lt members 56'. The curved section 57' of the end set of strut rnembers 5`'' izas conventional metal Iave~ ~7iti~' and radiopaque metal laver ~7R'. I}:e t1ex Iink 54' (llas a standard metal laver 54N' and a radiopaque metal layer 54R'. The central sets of stnit members 56' have cuned sections 53' with conventional metal iavers ~~N' and radiopaque metal layers 53R'.

It can be seen from FIG. 12C that the radiopaque metal layer 57R' of the end sets of strut members 52' is thicker than the radiopaque rrietal layers 54R' and 53R'.
In recent years, multi-layer photo-etchin,-, processes for rrmetals that can control the thiclcness of individual lavers have been developed so that the embodiment of FIG. 12C can be produced within the current state of the art of phot:o-etchin2. Using this approach, tvvo and three layer tubin'- is now available from several manufacture,s and can be photo-etched to make a stent with an optimal design which is high radiopacitv :`or the end set of strut members and reduced radiopacit,v for the central sets of stnrt rnembers. Specifically, a sterit with the characteristics as seen in FIG. 11-B or FIG. 12C would have the desirable attribute of end sets of strut menibers with ~-,reater radiopacitv than the remainder of the stent.

Various other modifications, adaptations, and alternative designs are of course possible in light of the above teachings. Thereforz, it should be understood at this time that within the scope of the appended claims the invention may be practiced otherwise than as specifically described lierein.

~'6

Claims (3)

What is claimed is:
1. A stent in the form of a thin-walled, multi-cellular, tubular structure having a longitudinal axis, the stent comprising a multiplicity of circumferential sets of strut members, each set of strut members being longitudinally separated each from the other and each set of strut members forming a closed, cylindrical portion of the stent, each set of strut members comprising a multiplicity of connected curved sections and diagonal sections, the sets of strut members including end sets of strut members located at each end of the stent and central sets of strut members positioned between the end sets of strut members, the curved sections of the central sets of strut members having a generally greater width than the width of the curved sections of the end sets of strut members and the diagonal sections of the central sets of strut members having a greater length as compared to the length of the diagonal sections of the end sets of strut members so as to provide approximately matched radial strength for the central sets of strut members and the end sets of strut members.
2. The stent of claim 1 wherein the width of the curved sections of the central sets of strut members is at least 0.0005 inch greater than the width of the curved sections of the end sets of strut members.
3. The stent of claim 1 wherein the length of the diagonal sections of the central sets of strut members is at least 0.001 inch greater than the length of the diagonal sections of the end sets of strut members.
CA002357650A 2000-09-22 2001-09-19 Stent with optimal strength and radiopacity characteristics Expired - Lifetime CA2357650C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2651808A CA2651808C (en) 2000-09-22 2001-09-19 Stent with optimal strength and radiopacity characteristics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23449700P 2000-09-22 2000-09-22
US60/234,497 2000-09-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2651808A Division CA2651808C (en) 2000-09-22 2001-09-19 Stent with optimal strength and radiopacity characteristics

Publications (2)

Publication Number Publication Date
CA2357650A1 CA2357650A1 (en) 2002-03-22
CA2357650C true CA2357650C (en) 2009-04-07

Family

ID=22881625

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002391624A Expired - Lifetime CA2391624C (en) 2000-09-22 2001-09-18 Stent with optimal strength and radio-opacity characteristics
CA002357650A Expired - Lifetime CA2357650C (en) 2000-09-22 2001-09-19 Stent with optimal strength and radiopacity characteristics
CA2651808A Expired - Lifetime CA2651808C (en) 2000-09-22 2001-09-19 Stent with optimal strength and radiopacity characteristics

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002391624A Expired - Lifetime CA2391624C (en) 2000-09-22 2001-09-18 Stent with optimal strength and radio-opacity characteristics

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2651808A Expired - Lifetime CA2651808C (en) 2000-09-22 2001-09-19 Stent with optimal strength and radiopacity characteristics

Country Status (12)

Country Link
US (5) US6699278B2 (en)
EP (2) EP1399091B1 (en)
JP (3) JP5124896B2 (en)
KR (1) KR100815360B1 (en)
AT (1) ATE339932T1 (en)
AU (3) AU782021B2 (en)
CA (3) CA2391624C (en)
DE (1) DE60123187T2 (en)
ES (1) ES2270965T3 (en)
MX (2) MXPA02005126A (en)
TW (1) TW539559B (en)
WO (1) WO2002024111A2 (en)

Families Citing this family (276)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE166782T1 (en) * 1994-02-25 1998-06-15 Fischell Robert STENT WITH A MULTIPLE CLOSED CIRCULAR STRUCTURES
US6602281B1 (en) * 1995-06-05 2003-08-05 Avantec Vascular Corporation Radially expansible vessel scaffold having beams and expansion joints
US6800080B1 (en) * 1996-05-03 2004-10-05 Scimed Life Systems, Inc. Medical retrieval device
US7341598B2 (en) 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US20020133222A1 (en) * 1997-03-05 2002-09-19 Das Gladwin S. Expandable stent having a plurality of interconnected expansion modules
US7753950B2 (en) 1997-08-13 2010-07-13 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6755856B2 (en) 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US6682554B2 (en) 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US7815763B2 (en) * 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US7887578B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US20050033399A1 (en) * 1998-12-03 2005-02-10 Jacob Richter Hybrid stent
US20060178727A1 (en) * 1998-12-03 2006-08-10 Jacob Richter Hybrid amorphous metal alloy stent
US20070219642A1 (en) * 1998-12-03 2007-09-20 Jacob Richter Hybrid stent having a fiber or wire backbone
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US20060122691A1 (en) * 1998-12-03 2006-06-08 Jacob Richter Hybrid stent
US8257425B2 (en) 1999-01-13 2012-09-04 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US6616689B1 (en) 2000-05-03 2003-09-09 Advanced Cardiovascular Systems, Inc. Intravascular stent
GB0020491D0 (en) 2000-08-18 2000-10-11 Angiomed Ag Stent with attached element and method of making such a stent
US6964680B2 (en) * 2001-02-05 2005-11-15 Conor Medsystems, Inc. Expandable medical device with tapered hinge
WO2002067653A2 (en) 2001-02-26 2002-09-06 Scimed Life Systems, Inc. Bifurcated stent and delivery system
US6939373B2 (en) 2003-08-20 2005-09-06 Advanced Cardiovascular Systems, Inc. Intravascular stent
US7520892B1 (en) 2001-06-28 2009-04-21 Advanced Cardiovascular Systems, Inc. Low profile stent with flexible link
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
JP3605388B2 (en) * 2001-10-16 2004-12-22 川澄化学工業株式会社 Stent
US6776794B1 (en) 2001-11-28 2004-08-17 Advanced Cardiovascular Systems, Inc. Stent pattern with mirror image
US7318833B2 (en) 2001-12-19 2008-01-15 Nmt Medical, Inc. PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
EP1467661A4 (en) * 2001-12-19 2008-11-05 Nmt Medical Inc Septal occluder and associated methods
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US6805707B1 (en) 2001-12-27 2004-10-19 Advanced Cardiovascular Systems, Inc. Stent with improved ring and link pattern
AU2003220502A1 (en) 2002-03-25 2003-10-13 Nmt Medical, Inc. Patent foramen ovale (pfo) closure clips
EP1348402A1 (en) * 2002-03-29 2003-10-01 Advanced Laser Applications Holding S.A. Intraluminal endoprosthesis, radially expandable, perforated for drug delivery
US7431729B2 (en) * 2002-06-05 2008-10-07 Nmt Medical, Inc. Patent foramen ovale (PFO) closure device with radial and circumferential support
US6656220B1 (en) 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent
US8080052B2 (en) * 2002-06-28 2011-12-20 Cordis Corporation Stent with diagonal flexible connecting links
US20040054398A1 (en) * 2002-09-13 2004-03-18 Cully Edward H. Stent device with multiple helix construction
DE10243136A1 (en) * 2002-09-17 2004-05-19 Campus Medizin & Technik Gmbh Stent for implantation in or around a hollow organ
US20040093066A1 (en) * 2002-09-26 2004-05-13 Durcan Jonathan P. Balloon expandable stent
US20060100695A1 (en) * 2002-09-27 2006-05-11 Peacock James C Iii Implantable stent with modified ends
US6638301B1 (en) * 2002-10-02 2003-10-28 Scimed Life Systems, Inc. Medical device with radiopacity
EP1556117A1 (en) 2002-10-25 2005-07-27 NMT Medical, Inc. Expandable sheath tubing
US20040093056A1 (en) 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7637942B2 (en) * 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7959671B2 (en) 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
DE10253633B4 (en) * 2002-11-13 2011-08-11 BIOTRONIK GmbH & Co. KG, 12359 supporting structure
US20070032879A1 (en) * 2002-12-02 2007-02-08 Levine Andy H Anti-buckling sleeve
US7766973B2 (en) 2005-01-19 2010-08-03 Gi Dynamics, Inc. Eversion resistant sleeves
US7122058B2 (en) 2002-12-02 2006-10-17 Gi Dynamics, Inc. Anti-obesity devices
US7678068B2 (en) * 2002-12-02 2010-03-16 Gi Dynamics, Inc. Atraumatic delivery devices
US7695446B2 (en) 2002-12-02 2010-04-13 Gi Dynamics, Inc. Methods of treatment using a bariatric sleeve
US7608114B2 (en) 2002-12-02 2009-10-27 Gi Dynamics, Inc. Bariatric sleeve
US7025791B2 (en) 2002-12-02 2006-04-11 Gi Dynamics, Inc. Bariatric sleeve
ES2626981T3 (en) 2002-12-09 2017-07-26 W.L. Gore & Associates, Inc. Septal closure device
US8105373B2 (en) * 2002-12-16 2012-01-31 Boston Scientific Scimed, Inc. Flexible stent with improved axial strength
US20070239251A1 (en) * 2002-12-31 2007-10-11 Abbott Cardiovascular Systems Inc. Flexible stent
CN100558320C (en) * 2003-03-19 2009-11-11 先进生物假体表面有限公司 Intracavity stent with intercolumniation interconnecting members
US20050283042A1 (en) * 2003-03-28 2005-12-22 Steve Meyer Cardiac harness having radiopaque coating and method of use
WO2004084769A2 (en) * 2003-03-28 2004-10-07 Damian John Conway Stents
US7637934B2 (en) 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
DE10317241A1 (en) 2003-04-10 2004-10-28 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin stent
US7604660B2 (en) 2003-05-01 2009-10-20 Merit Medical Systems, Inc. Bifurcated medical appliance delivery apparatus and method
WO2004108201A1 (en) * 2003-06-02 2004-12-16 Nipro Corporation Soft stent with excellent follow-up capability to blood vessel
US20040254637A1 (en) * 2003-06-16 2004-12-16 Endotex Interventional Systems, Inc. Sleeve stent marker
US9155639B2 (en) * 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US9039755B2 (en) 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
WO2005006990A2 (en) 2003-07-14 2005-01-27 Nmt Medical, Inc. Tubular patent foramen ovale (pfo) closure device with catch system
DE602004017750D1 (en) 2003-08-19 2008-12-24 Nmt Medical Inc Expandable lock hose
US8298280B2 (en) 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
DE10342757A1 (en) * 2003-09-16 2005-04-07 Campus Gmbh & Co. Kg Stent with terminal anchoring elements
US20050096725A1 (en) * 2003-10-29 2005-05-05 Pomeranz Mark L. Expandable stent having removable slat members
US20060212042A1 (en) * 2005-03-17 2006-09-21 Lamport Ronald B Removal and repositioning device
US8057420B2 (en) 2003-12-09 2011-11-15 Gi Dynamics, Inc. Gastrointestinal implant with drawstring
US20050273119A1 (en) 2003-12-09 2005-12-08 Nmt Medical, Inc. Double spiral patent foramen ovale closure clamp
WO2005060882A1 (en) 2003-12-09 2005-07-07 Gi Dynamics, Inc. Apparatus to be anchored within the gastrointestinal tract and anchoring method
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
US7243408B2 (en) * 2004-02-09 2007-07-17 Boston Scientific Scimed, Inc. Process method for attaching radio opaque markers to shape memory stent
US8992592B2 (en) * 2004-12-29 2015-03-31 Boston Scientific Scimed, Inc. Medical devices including metallic films
US7901447B2 (en) * 2004-12-29 2011-03-08 Boston Scientific Scimed, Inc. Medical devices including a metallic film and at least one filament
US8591568B2 (en) * 2004-03-02 2013-11-26 Boston Scientific Scimed, Inc. Medical devices including metallic films and methods for making same
US20060142838A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for loading and deploying same
US8998973B2 (en) * 2004-03-02 2015-04-07 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8632580B2 (en) * 2004-12-29 2014-01-21 Boston Scientific Scimed, Inc. Flexible medical devices including metallic films
JP2007526087A (en) 2004-03-03 2007-09-13 エヌエムティー メディカル, インコーポレイティッド Delivery / recovery system for septal occluder
US8858616B2 (en) 2004-03-16 2014-10-14 Admedes Schuessler Gmbh Stent having a bridge structure
DE102004012981B4 (en) * 2004-03-16 2009-01-02 Alveolus Inc. stent
DE102004012837B4 (en) * 2004-03-16 2006-09-14 Admedes Schuessler Gmbh Stent having a web structure and method of making the same
US8007528B2 (en) 2004-03-17 2011-08-30 Boston Scientific Scimed, Inc. Bifurcated stent
US20050267524A1 (en) 2004-04-09 2005-12-01 Nmt Medical, Inc. Split ends closure device
US8361110B2 (en) 2004-04-26 2013-01-29 W.L. Gore & Associates, Inc. Heart-shaped PFO closure device
DE102004022044B4 (en) 2004-05-03 2008-12-18 Qualimed Innovative Medizinprodukte Gmbh stent
US8308760B2 (en) 2004-05-06 2012-11-13 W.L. Gore & Associates, Inc. Delivery systems and methods for PFO closure device with two anchors
US7842053B2 (en) * 2004-05-06 2010-11-30 Nmt Medical, Inc. Double coil occluder
WO2005110240A1 (en) 2004-05-07 2005-11-24 Nmt Medical, Inc. Catching mechanisms for tubular septal occluder
US20060122686A1 (en) * 2004-05-10 2006-06-08 Ran Gilad Stent and method of manufacturing same
US20050261757A1 (en) * 2004-05-21 2005-11-24 Conor Medsystems, Inc. Stent with contoured bridging element
US20050273156A1 (en) * 2004-06-07 2005-12-08 Rober Burgermeister Biocompatible alloy for implantable medical devices
EP1753369B1 (en) 2004-06-08 2013-05-29 Advanced Stent Technologies, Inc. Stent with protruding branch portion for bifurcated vessels
US7763064B2 (en) * 2004-06-08 2010-07-27 Medinol, Ltd. Stent having struts with reverse direction curvature
US20050276718A1 (en) * 2004-06-09 2005-12-15 Robert Burgermeister Cobalt-nickel-chromium biocompatible alloy for implantable medical devices
US8999364B2 (en) 2004-06-15 2015-04-07 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
EP1773871B1 (en) 2004-06-17 2014-10-15 Thrasos Innovation, Inc. Tdf-related compounds and analogs thereof
CA2572277A1 (en) * 2004-06-30 2006-01-12 Cordis Corporation Intraluminal medical device having asymetrical members and method for optimization
JP4995081B2 (en) * 2004-06-30 2012-08-08 コーディス・コーポレイション Stent having asymmetric members of unequal length
US7794493B2 (en) * 2004-06-30 2010-09-14 Cordis Corporation Magnetic resonance imaging compatibility alloy for implantable medical devices
ATE506042T1 (en) 2004-07-09 2011-05-15 Gi Dynamics Inc DEVICES FOR PLACEMENT OF A GASTROINTESTINAL SLEEVE
US20060020325A1 (en) * 2004-07-26 2006-01-26 Robert Burgermeister Material for high strength, controlled recoil stent
EP1789107B1 (en) 2004-08-30 2009-05-27 Interstitial Therapeutics Medical stent provided with inhibitors of atp synthesis
US7815591B2 (en) 2004-09-17 2010-10-19 Gi Dynamics, Inc. Atraumatic gastrointestinal anchor
US8764848B2 (en) 2004-09-24 2014-07-01 W.L. Gore & Associates, Inc. Occluder device double securement system for delivery/recovery of such occluder device
US7887579B2 (en) * 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
US20060079954A1 (en) * 2004-10-08 2006-04-13 Robert Burgermeister Geometry and material for high strength, high flexibility, controlled recoil stent
US7147659B2 (en) * 2004-10-28 2006-12-12 Cordis Neurovascular, Inc. Expandable stent having a dissolvable portion
US7156871B2 (en) * 2004-10-28 2007-01-02 Cordis Neurovascular, Inc. Expandable stent having a stabilized portion
US20060129226A1 (en) * 2004-12-10 2006-06-15 Robert Burgermeister Material for flexible connectors in high strength, high flexibility, controlled recoil stent
US20060136040A1 (en) * 2004-12-17 2006-06-22 Robert Burgermeister Longitudinal design and improved material for flexible connectors in high strength, high flexibility, controlled recoil stent
US7727273B2 (en) * 2005-01-13 2010-06-01 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US7771382B2 (en) 2005-01-19 2010-08-10 Gi Dynamics, Inc. Resistive anti-obesity devices
US20060200229A1 (en) * 2005-03-03 2006-09-07 Robert Burgermeister Geometry and material for use in high strength, high flexibility, controlled recoil drug eluting stents
US7837726B2 (en) 2005-03-14 2010-11-23 Abbott Laboratories Visible endoprosthesis
US20070213810A1 (en) * 2005-03-14 2007-09-13 Richard Newhauser Segmented endoprosthesis
EP1868507A1 (en) 2005-03-18 2007-12-26 NMT Medical, Inc. Catch member for pfo occluder
US8435280B2 (en) 2005-03-31 2013-05-07 Boston Scientific Scimed, Inc. Flexible stent with variable width elements
US8628565B2 (en) * 2005-04-13 2014-01-14 Abbott Cardiovascular Systems Inc. Intravascular stent
WO2006124824A1 (en) * 2005-05-13 2006-11-23 Alveolus, Inc. Drainage stent and associated method
US7731654B2 (en) * 2005-05-13 2010-06-08 Merit Medical Systems, Inc. Delivery device with viewing window and associated method
US7854760B2 (en) * 2005-05-16 2010-12-21 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8480728B2 (en) 2005-05-26 2013-07-09 Boston Scientific Scimed, Inc. Stent side branch deployment initiation geometry
US8317855B2 (en) 2005-05-26 2012-11-27 Boston Scientific Scimed, Inc. Crimpable and expandable side branch cell
US20060276910A1 (en) * 2005-06-01 2006-12-07 Jan Weber Endoprostheses
US7976488B2 (en) 2005-06-08 2011-07-12 Gi Dynamics, Inc. Gastrointestinal anchor compliance
WO2006138547A1 (en) * 2005-06-15 2006-12-28 Med Institute, Inc Intraluminal device with improved tapered beams
EP1895952B1 (en) 2005-06-15 2020-04-15 Cook Medical Technologies LLC Intraluminal device with unsymmetric tapered beams
EP2364676B1 (en) 2005-06-30 2018-12-19 Abbott Laboratories Endoprosthesis having foot extensions
US20070043427A1 (en) * 2005-08-19 2007-02-22 Medlogics Device Corporation Lumen-supporting stents
US20070049801A1 (en) * 2005-08-24 2007-03-01 Lamport Ronald B Endoscope accessory
US7731741B2 (en) 2005-09-08 2010-06-08 Boston Scientific Scimed, Inc. Inflatable bifurcation stent
US8043366B2 (en) 2005-09-08 2011-10-25 Boston Scientific Scimed, Inc. Overlapping stent
US8038706B2 (en) 2005-09-08 2011-10-18 Boston Scientific Scimed, Inc. Crown stent assembly
HUE026634T2 (en) 2005-09-20 2016-07-28 Thrasos Innovation Inc TDF-related compounds and analogs thereof
US20070112418A1 (en) 2005-11-14 2007-05-17 Boston Scientific Scimed, Inc. Stent with spiral side-branch support designs
US8052714B2 (en) * 2005-11-22 2011-11-08 Medtronic Vascular, Inc. Radiopaque fibers and filtration matrices
US7914573B2 (en) * 2005-12-13 2011-03-29 Cordis Corporation Polymeric stent having modified molecular structures
US8343211B2 (en) 2005-12-14 2013-01-01 Boston Scientific Scimed, Inc. Connectors for bifurcated stent
US8435284B2 (en) 2005-12-14 2013-05-07 Boston Scientific Scimed, Inc. Telescoping bifurcated stent
US8518100B2 (en) * 2005-12-19 2013-08-27 Advanced Cardiovascular Systems, Inc. Drug eluting stent for the treatment of dialysis graft stenoses
US7540881B2 (en) 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
WO2007073566A1 (en) 2005-12-22 2007-06-28 Nmt Medical, Inc. Catch members for occluder devices
US20070156230A1 (en) 2006-01-04 2007-07-05 Dugan Stephen R Stents with radiopaque markers
US20070191926A1 (en) * 2006-02-14 2007-08-16 Advanced Cardiovascular Systems, Inc. Stent pattern for high stent retention
US7833264B2 (en) 2006-03-06 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent
US8298278B2 (en) * 2006-03-07 2012-10-30 Boston Scientific Scimed, Inc. Bifurcated stent with improvement securement
US8870913B2 (en) 2006-03-31 2014-10-28 W.L. Gore & Associates, Inc. Catch system with locking cap for patent foramen ovale (PFO) occluder
US8551135B2 (en) * 2006-03-31 2013-10-08 W.L. Gore & Associates, Inc. Screw catch mechanism for PFO occluder and method of use
WO2007115125A2 (en) 2006-03-31 2007-10-11 Nmt Medical, Inc. Deformable flap catch mechanism for occluder device
GB0609841D0 (en) 2006-05-17 2006-06-28 Angiomed Ag Bend-capable tubular prosthesis
GB0609911D0 (en) 2006-05-18 2006-06-28 Angiomed Ag Bend-capable stent prosthesis
US20130325104A1 (en) 2006-05-26 2013-12-05 Abbott Cardiovascular Systems Inc. Stents With Radiopaque Markers
AU2007258592B2 (en) 2006-06-06 2012-10-25 Cook Incorporated Stent with a crush-resistant zone
US7819836B2 (en) 2006-06-23 2010-10-26 Gi Dynamics, Inc. Resistive anti-obesity devices
EP2051673A2 (en) 2006-06-23 2009-04-29 Boston Scientific Limited Bifurcated stent with twisted hinges
KR100795125B1 (en) * 2006-07-31 2008-01-17 연세대학교 산학협력단 Coronary artery stent
GB0616579D0 (en) 2006-08-21 2006-09-27 Angiomed Ag Self-expanding stent
US8882826B2 (en) * 2006-08-22 2014-11-11 Abbott Cardiovascular Systems Inc. Intravascular stent
DE07841109T1 (en) * 2006-08-22 2010-02-11 Abbott Cardiovascular Systems Inc., Santa Clara INTRAVASCULAR STENT
US8834554B2 (en) * 2006-08-22 2014-09-16 Abbott Cardiovascular Systems Inc. Intravascular stent
US20080051879A1 (en) * 2006-08-23 2008-02-28 Cook Incorporated Methods of treating venous valve related conditions with a flow-modifying implantable medical device
GB0616999D0 (en) 2006-08-29 2006-10-04 Angiomed Ag Annular mesh
WO2008028964A2 (en) 2006-09-07 2008-03-13 Angiomed Gmbh & Co. Medizintechnik Kg Helical implant having different ends
US8216267B2 (en) 2006-09-12 2012-07-10 Boston Scientific Scimed, Inc. Multilayer balloon for bifurcated stent delivery and methods of making and using the same
US8778009B2 (en) 2006-10-06 2014-07-15 Abbott Cardiovascular Systems Inc. Intravascular stent
US7951191B2 (en) 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
US20080097571A1 (en) * 2006-10-21 2008-04-24 Paragon Intellectual Properties, Llc Deformable lumen support devices and methods of use
US8206429B2 (en) 2006-11-02 2012-06-26 Boston Scientific Scimed, Inc. Adjustable bifurcation catheter incorporating electroactive polymer and methods of making and using the same
GB0622465D0 (en) 2006-11-10 2006-12-20 Angiomed Ag Stent
US7842082B2 (en) 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US20080133000A1 (en) * 2006-12-01 2008-06-05 Medtronic Vascular, Inc. Bifurcated Stent With Variable Length Branches
GB0624419D0 (en) 2006-12-06 2007-01-17 Angiomed Ag Stenting ring with marker
US8801647B2 (en) 2007-02-22 2014-08-12 Gi Dynamics, Inc. Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks
US8974514B2 (en) 2007-03-13 2015-03-10 Abbott Cardiovascular Systems Inc. Intravascular stent with integrated link and ring strut
US8118861B2 (en) 2007-03-28 2012-02-21 Boston Scientific Scimed, Inc. Bifurcation stent and balloon assemblies
US8647376B2 (en) 2007-03-30 2014-02-11 Boston Scientific Scimed, Inc. Balloon fold design for deployment of bifurcated stent petal architecture
GB0706499D0 (en) 2007-04-03 2007-05-09 Angiomed Ag Bendable stent
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
WO2008131167A1 (en) 2007-04-18 2008-10-30 Nmt Medical, Inc. Flexible catheter system
US8128679B2 (en) * 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US8016874B2 (en) 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US8211162B2 (en) 2007-05-25 2012-07-03 Boston Scientific Scimed, Inc. Connector node for durable stent
US20080300671A1 (en) * 2007-06-04 2008-12-04 Gil Vardi Stent having high expansion ratio
US9144508B2 (en) 2007-07-19 2015-09-29 Back Bay Medical Inc. Radially expandable stent
GB0717481D0 (en) 2007-09-07 2007-10-17 Angiomed Ag Self-expansible stent with radiopaque markers
US7959669B2 (en) 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
AU2008308474B2 (en) 2007-10-04 2014-07-24 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
EP3505142B1 (en) * 2007-10-19 2020-10-28 CeloNova Biosciences, Inc. Implantable and lumen-supporting stents
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
US7972373B2 (en) * 2007-12-19 2011-07-05 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US8337544B2 (en) 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US8920488B2 (en) * 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US8277501B2 (en) 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
US8747456B2 (en) 2007-12-31 2014-06-10 Boston Scientific Scimed, Inc. Bifurcation stent delivery system and methods
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US10898620B2 (en) 2008-06-20 2021-01-26 Razmodics Llc Composite stent having multi-axial flexibility and method of manufacture thereof
US8206635B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US8206636B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US20100057187A1 (en) * 2008-08-26 2010-03-04 Caldarise Salvatore G Intravascular stent having imrproved design for loading and deploying
US20100145433A1 (en) * 2008-09-30 2010-06-10 Abbott Cardiovascular Systems, Inc. Endoprostheses for deployment in a body lumen
US8123815B2 (en) 2008-11-24 2012-02-28 Biomet Manufacturing Corp. Multiple bearing acetabular prosthesis
US8956389B2 (en) 2009-06-22 2015-02-17 W. L. Gore & Associates, Inc. Sealing device and delivery system
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
US8308810B2 (en) 2009-07-14 2012-11-13 Biomet Manufacturing Corp. Multiple bearing acetabular prosthesis
EP2485688B1 (en) * 2009-10-06 2019-09-04 Sahajanand Medical Technologies Private Limited Bioresorbable vascular implant having homogenously distributed stresses under a radial load
AU2010313389A1 (en) * 2009-10-30 2012-05-31 Cordis Corporation Intraluminal device with improved flexibility and durability
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
DE102010008362A1 (en) * 2010-02-17 2011-08-18 Transcatheter Technologies GmbH, 93053 Medical implant which is expandable from a non-expanded state
KR101015329B1 (en) * 2010-04-23 2011-02-16 강원대학교산학협력단 Surgical stent
US9301864B2 (en) 2010-06-08 2016-04-05 Veniti, Inc. Bi-directional stent delivery system
US8864811B2 (en) 2010-06-08 2014-10-21 Veniti, Inc. Bi-directional stent delivery system
US9233014B2 (en) 2010-09-24 2016-01-12 Veniti, Inc. Stent with support braces
WO2012087842A1 (en) 2010-12-23 2012-06-28 The Foundry, Llc System for mitral valve repair and replacement
EP2658484A1 (en) 2010-12-30 2013-11-06 Boston Scientific Scimed, Inc. Multi stage opening stent designs
WO2012119037A1 (en) 2011-03-03 2012-09-07 Boston Scientific Scimed, Inc. Stent with reduced profile
JP2014511247A (en) 2011-03-03 2014-05-15 ボストン サイエンティフィック サイムド,インコーポレイテッド Low strain high strength stent
JP5872692B2 (en) 2011-06-21 2016-03-01 トゥエルヴ, インコーポレイテッド Artificial therapy device
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
AU2012325809B2 (en) 2011-10-19 2016-01-21 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9763780B2 (en) 2011-10-19 2017-09-19 Twelve, Inc. Devices, systems and methods for heart valve replacement
US9655722B2 (en) 2011-10-19 2017-05-23 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
CA3090422C (en) 2011-10-19 2023-08-01 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
US9579198B2 (en) 2012-03-01 2017-02-28 Twelve, Inc. Hydraulic delivery systems for prosthetic heart valve devices and associated methods
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US20140094900A1 (en) * 2012-10-01 2014-04-03 Brigham Young University Compliant biocompatible device and method of manufacture
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
US9180031B2 (en) 2013-03-15 2015-11-10 Covidien Lp Stent with varying radius between struts
US9259335B2 (en) 2013-03-15 2016-02-16 Covidien Lp Stent
US9545301B2 (en) 2013-03-15 2017-01-17 Covidien Lp Coated medical devices and methods of making and using same
US10111747B2 (en) 2013-05-20 2018-10-30 Twelve, Inc. Implantable heart valve devices, mitral valve repair devices and associated systems and methods
CN103550017B (en) * 2013-08-16 2015-12-09 江苏大学 A kind of intravascular stent being applicable to conical blood vessel
US9668890B2 (en) * 2013-11-22 2017-06-06 Covidien Lp Anti-thrombogenic medical devices and methods
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
US9999527B2 (en) 2015-02-11 2018-06-19 Abbott Cardiovascular Systems Inc. Scaffolds having radiopaque markers
US9700443B2 (en) 2015-06-12 2017-07-11 Abbott Cardiovascular Systems Inc. Methods for attaching a radiopaque marker to a scaffold
US10238490B2 (en) 2015-08-21 2019-03-26 Twelve, Inc. Implant heart valve devices, mitral valve repair devices and associated systems and methods
US10265089B2 (en) 2016-02-12 2019-04-23 Covidien Lp Vascular device visibility
US10052185B2 (en) 2016-02-12 2018-08-21 Covidien Lp Vascular device marker attachment
US10130465B2 (en) 2016-02-23 2018-11-20 Abbott Cardiovascular Systems Inc. Bifurcated tubular graft for treating tricuspid regurgitation
CN116172753A (en) 2016-04-29 2023-05-30 美敦力瓦斯科尔勒公司 Prosthetic heart valve devices having tethered anchors and associated systems and methods
US10905572B2 (en) 2016-11-14 2021-02-02 Covidien Lp Stent
US10449069B2 (en) 2016-11-14 2019-10-22 Covidien Lp Stent
US10258488B2 (en) 2016-11-14 2019-04-16 Covidien Lp Stent
US10433961B2 (en) 2017-04-18 2019-10-08 Twelve, Inc. Delivery systems with tethers for prosthetic heart valve devices and associated methods
US10702378B2 (en) 2017-04-18 2020-07-07 Twelve, Inc. Prosthetic heart valve device and associated systems and methods
US10575950B2 (en) 2017-04-18 2020-03-03 Twelve, Inc. Hydraulic systems for delivering prosthetic heart valve devices and associated methods
US10792151B2 (en) 2017-05-11 2020-10-06 Twelve, Inc. Delivery systems for delivering prosthetic heart valve devices and associated methods
US10646338B2 (en) 2017-06-02 2020-05-12 Twelve, Inc. Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods
US10709591B2 (en) 2017-06-06 2020-07-14 Twelve, Inc. Crimping device and method for loading stents and prosthetic heart valves
US10786352B2 (en) 2017-07-06 2020-09-29 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10729541B2 (en) 2017-07-06 2020-08-04 Twelve, Inc. Prosthetic heart valve devices and associated systems and methods
US10238513B2 (en) 2017-07-19 2019-03-26 Abbott Cardiovascular Systems Inc. Intravascular stent
US10835398B2 (en) 2017-11-03 2020-11-17 Covidien Lp Meshes and devices for treating vascular defects
CN109984864B (en) * 2017-12-29 2020-07-17 先健科技(深圳)有限公司 Stent for branch vessels
CN113633433A (en) * 2021-10-15 2021-11-12 微创神通医疗科技(上海)有限公司 Vascular implant

Family Cites Families (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US359802A (en) * 1887-03-22 Eugene o
FR566807A (en) 1923-01-12 1924-02-21 Improvements in the use of gases escaping from water tube boilers
GB662307A (en) 1948-09-01 1951-12-05 Cleveland Punch & Shear Works Clutch and brake structure
GB1205743A (en) 1966-07-15 1970-09-16 Nat Res Dev Surgical dilator
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4388735A (en) 1980-11-03 1983-06-21 Shiley Inc. Low profile prosthetic xenograft heart valve
AT392733B (en) 1981-09-16 1991-05-27 Medinvent Sa DEVICE FOR TREATING BLOOD VESSELS OR THE LIKE.
DE3205942A1 (en) 1982-02-19 1983-09-08 Ljubomir Dr. Skopje Vasilev Balloon-tipped catheter with a mobile tip which permits complete voiding of the bladder
US4503569A (en) 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US5275622A (en) 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4907336A (en) 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US5041126A (en) 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US4969458A (en) 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US4990131A (en) 1987-09-01 1991-02-05 Herbert Dardik Tubular prostheses for vascular reconstructive surgery and process for preparing same
US5131908A (en) 1987-09-01 1992-07-21 Herbert Dardik Tubular prosthesis for vascular reconstructive surgery and process for preparing same
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5266073A (en) 1987-12-08 1993-11-30 Wall W Henry Angioplasty stent
US5192307A (en) 1987-12-08 1993-03-09 Wall W Henry Angioplasty stent
CA1322628C (en) 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
CH678393A5 (en) 1989-01-26 1991-09-13 Ulrich Prof Dr Med Sigwart
US5163958A (en) 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
US4990155A (en) 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US4994071A (en) 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5015253A (en) 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
US5171262A (en) 1989-06-15 1992-12-15 Cordis Corporation Non-woven endoprosthesis
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
IE73670B1 (en) 1989-10-02 1997-07-02 Medtronic Inc Articulated stent
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5176660A (en) 1989-10-23 1993-01-05 Cordis Corporation Catheter having reinforcing strands
IL94138A (en) 1990-04-19 1997-03-18 Instent Inc Device for the treatment of constricted fluid conducting ducts
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5122154A (en) 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
US5449372A (en) 1990-10-09 1995-09-12 Scimed Lifesystems, Inc. Temporary stent and methods for use and manufacture
DE9116881U1 (en) 1990-10-09 1994-07-07 Cook Inc Percutaneous stent
US5222971A (en) 1990-10-09 1993-06-29 Scimed Life Systems, Inc. Temporary stent and methods for use and manufacture
US5217483A (en) 1990-11-28 1993-06-08 Numed, Inc. Intravascular radially expandable stent
US5178618A (en) 1991-01-16 1993-01-12 Brigham And Womens Hospital Method and device for recanalization of a body passageway
US5354257A (en) 1991-01-29 1994-10-11 Med Institute, Inc. Minimally invasive medical device for providing a radiation treatment
US5135536A (en) 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5116365A (en) 1991-02-22 1992-05-26 Cordis Corporation Stent apparatus and method for making
US5304200A (en) 1991-05-29 1994-04-19 Cordis Corporation Welded radially expandable endoprosthesis and the like
US5527354A (en) 1991-06-28 1996-06-18 Cook Incorporated Stent formed of half-round wire
US5314472A (en) 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
USD359802S (en) 1991-06-28 1995-06-27 Cook Incorporated Vascular stent
US5443498A (en) 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5290305A (en) 1991-10-11 1994-03-01 Kanji Inoue Appliance collapsible for insertion into human organs and capable of resilient restoration
US5387235A (en) 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
CA2380683C (en) 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
JP3065404B2 (en) 1991-11-18 2000-07-17 シャープ株式会社 External magnetic field generator
US5258021A (en) 1992-01-27 1993-11-02 Duran Carlos G Sigmoid valve annuloplasty ring
CA2087132A1 (en) 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
US5405377A (en) 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
DE4206843C2 (en) 1992-03-04 1994-03-24 Heraeus Elektrochemie Electrochemical cells for performing electrochemical processes
US5282823A (en) 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5370683A (en) 1992-03-25 1994-12-06 Cook Incorporated Vascular stent
FR2689388B1 (en) 1992-04-07 1999-07-16 Celsa Lg PERFECTIONALLY RESORBABLE BLOOD FILTER.
WO1995014500A1 (en) 1992-05-01 1995-06-01 Beth Israel Hospital A stent
US5354308A (en) 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
US5342387A (en) 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
US5496365A (en) 1992-07-02 1996-03-05 Sgro; Jean-Claude Autoexpandable vascular endoprosthesis
US5382261A (en) 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5449382A (en) 1992-11-04 1995-09-12 Dayton; Michael P. Minimally invasive bioactivated endoprosthesis for vessel repair
US5342348A (en) 1992-12-04 1994-08-30 Kaplan Aaron V Method and device for treating and enlarging body lumens
BE1006440A3 (en) 1992-12-21 1994-08-30 Dereume Jean Pierre Georges Em Luminal endoprosthesis AND METHOD OF PREPARATION.
US5370691A (en) 1993-01-26 1994-12-06 Target Therapeutics, Inc. Intravascular inflatable stent
US5441515A (en) 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5411549A (en) 1993-07-13 1995-05-02 Scimed Life Systems, Inc. Selectively expandable, retractable and removable stent
US5389106A (en) 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
JP2703510B2 (en) 1993-12-28 1998-01-26 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Expandable stent and method of manufacturing the same
US5403341A (en) 1994-01-24 1995-04-04 Solar; Ronald J. Parallel flow endovascular stent and deployment apparatus therefore
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5443477A (en) 1994-02-10 1995-08-22 Stentco, Inc. Apparatus and method for deployment of radially expandable stents by a mechanical linkage
US5643312A (en) 1994-02-25 1997-07-01 Fischell Robert Stent having a multiplicity of closed circular structures
ATE166782T1 (en) 1994-02-25 1998-06-15 Fischell Robert STENT WITH A MULTIPLE CLOSED CIRCULAR STRUCTURES
US5441516A (en) 1994-03-03 1995-08-15 Scimed Lifesystems Inc. Temporary stent
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
EP0679372B1 (en) * 1994-04-25 1999-07-28 Advanced Cardiovascular Systems, Inc. Radiopaque stent markers
US5397355A (en) 1994-07-19 1995-03-14 Stentco, Inc. Intraluminal stent
NL9500094A (en) 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.
CA2186029C (en) 1995-03-01 2003-04-08 Brian J. Brown Improved longitudinally flexible expandable stent
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
EP0734698B9 (en) 1995-04-01 2006-07-05 Variomed AG Stent for transluminal implantation into hollow organs
NZ285241A (en) * 1995-04-26 1999-03-29 Medinol Ltd Articulated stent with area of inflection between neighbouring portions
FR2733682B1 (en) 1995-05-04 1997-10-31 Dibie Alain ENDOPROSTHESIS FOR THE TREATMENT OF STENOSIS ON BIFURCATIONS OF BLOOD VESSELS AND LAYING EQUIPMENT THEREFOR
US5609629A (en) * 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
AU716005B2 (en) 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
US5669924A (en) 1995-10-26 1997-09-23 Shaknovich; Alexander Y-shuttle stent assembly for bifurcating vessels and method of using the same
DE69735530T2 (en) 1996-01-04 2006-08-17 Chuter, Timothy A.M. Dr., Atherton FLAT WIRE STENT
CA2192520A1 (en) * 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
DE19614160A1 (en) 1996-04-10 1997-10-16 Variomed Ag Stent for transluminal implantation in hollow organs
NZ331269A (en) * 1996-04-10 2000-01-28 Advanced Cardiovascular System Expandable stent, its structural strength varying along its length
US6241760B1 (en) * 1996-04-26 2001-06-05 G. David Jang Intravascular stent
UA58485C2 (en) 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US6174329B1 (en) 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
US5807404A (en) 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
EP0944366B1 (en) 1996-11-04 2006-09-13 Advanced Stent Technologies, Inc. Extendible double stent
US5827321A (en) * 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
WO1998040035A1 (en) * 1997-03-13 1998-09-17 United States Surgical Corporation Flexible tissue supporting device
US6451049B2 (en) 1998-04-29 2002-09-17 Sorin Biomedica Cardio, S.P.A. Stents for angioplasty
US5913895A (en) 1997-06-02 1999-06-22 Isostent, Inc. Intravascular stent with enhanced rigidity strut members
US5843175A (en) * 1997-06-13 1998-12-01 Global Therapeutics, Inc. Enhanced flexibility surgical stent
FR2764794B1 (en) * 1997-06-20 1999-11-12 Nycomed Lab Sa EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS
ES2290995T3 (en) 1997-09-24 2008-02-16 Med Institute, Inc. RADIALLY EXPANDABLE ENDOPROTESIS.
US6042606A (en) * 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
NO311781B1 (en) 1997-11-13 2002-01-28 Medinol Ltd Metal multilayer stents
US5964798A (en) 1997-12-16 1999-10-12 Cardiovasc, Inc. Stent having high radial strength
US6190406B1 (en) * 1998-01-09 2001-02-20 Nitinal Development Corporation Intravascular stent having tapered struts
WO1999044535A1 (en) * 1998-03-05 1999-09-10 Boston Scientific Limited Intraluminal stent
US5935162A (en) 1998-03-16 1999-08-10 Medtronic, Inc. Wire-tubular hybrid stent
US5911754A (en) 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6190403B1 (en) 1998-11-13 2001-02-20 Cordis Corporation Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity
US6273910B1 (en) * 1999-03-11 2001-08-14 Advanced Cardiovascular Systems, Inc. Stent with varying strut geometry
AU5903400A (en) * 1999-06-30 2001-01-31 Advanced Cardiovascular Systems Inc. Variable thickness stent and method of manufacture thereof
US6540774B1 (en) * 1999-08-31 2003-04-01 Advanced Cardiovascular Systems, Inc. Stent design with end rings having enhanced strength and radiopacity

Also Published As

Publication number Publication date
CA2651808A1 (en) 2002-03-22
JP2011177557A (en) 2011-09-15
US8454677B2 (en) 2013-06-04
CA2391624C (en) 2007-11-06
EP1190685A2 (en) 2002-03-27
US20020058989A1 (en) 2002-05-16
TW539559B (en) 2003-07-01
US20020072792A1 (en) 2002-06-13
EP1399091A2 (en) 2004-03-24
AU2005205781B2 (en) 2007-01-04
WO2002024111A2 (en) 2002-03-28
KR100815360B1 (en) 2008-03-19
US6699278B2 (en) 2004-03-02
AU773171B2 (en) 2004-05-20
MXPA02005126A (en) 2003-09-25
AU8912801A (en) 2002-04-02
DE60123187T2 (en) 2007-09-06
JP2004522463A (en) 2004-07-29
JP2002102358A (en) 2002-04-09
WO2002024111A3 (en) 2003-12-24
ATE339932T1 (en) 2006-10-15
AU2005205781A1 (en) 2005-09-29
CA2391624A1 (en) 2002-03-28
EP1399091B1 (en) 2013-05-29
CA2651808C (en) 2013-01-08
JP5124896B2 (en) 2013-01-23
MXPA01009526A (en) 2003-03-27
US6669722B2 (en) 2003-12-30
EP1190685A3 (en) 2004-01-02
AU782021B2 (en) 2005-06-30
KR20020023647A (en) 2002-03-29
US20020058988A1 (en) 2002-05-16
CA2357650A1 (en) 2002-03-22
US20040102836A1 (en) 2004-05-27
ES2270965T3 (en) 2007-04-16
US7338519B2 (en) 2008-03-04
DE60123187D1 (en) 2006-11-02
US20080109068A1 (en) 2008-05-08
AU7217101A (en) 2002-03-28
EP1190685B1 (en) 2006-09-20

Similar Documents

Publication Publication Date Title
CA2357650C (en) Stent with optimal strength and radiopacity characteristics
US7789905B2 (en) Apparatus for a stent having an expandable web structure
US7169174B2 (en) Hybrid stent
AU2005201815B9 (en) Stent with optimal strength and radio-opacity characteristics

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20210920